nodes	percent_of_prediction	percent_of_DWPC	metapath
Conjugated Estrogens—prostate cancer—bone cancer	0.46	1	CtDrD
Conjugated Estrogens—CYP3A4—bone cancer	0.106	1	CbGaD
Conjugated Estrogens—ABCC11—Methotrexate—bone cancer	0.0516	0.155	CbGbCtD
Conjugated Estrogens—SLCO3A1—Methotrexate—bone cancer	0.0354	0.107	CbGbCtD
Conjugated Estrogens—SLCO1C1—Methotrexate—bone cancer	0.0226	0.0682	CbGbCtD
Conjugated Estrogens—ABCC3—Cisplatin—bone cancer	0.0219	0.066	CbGbCtD
Conjugated Estrogens—ABCC1—Epirubicin—bone cancer	0.017	0.0511	CbGbCtD
Conjugated Estrogens—ABCC3—Doxorubicin—bone cancer	0.0147	0.0442	CbGbCtD
Conjugated Estrogens—ABCC3—Methotrexate—bone cancer	0.0142	0.0429	CbGbCtD
Conjugated Estrogens—SLCO1B3—Methotrexate—bone cancer	0.0126	0.0381	CbGbCtD
Conjugated Estrogens—SLC22A11—Methotrexate—bone cancer	0.0117	0.0352	CbGbCtD
Conjugated Estrogens—ABCC2—Carboplatin—bone cancer	0.0117	0.0351	CbGbCtD
Conjugated Estrogens—ABCC4—Methotrexate—bone cancer	0.0109	0.0327	CbGbCtD
Conjugated Estrogens—ABCG2—Carboplatin—bone cancer	0.0105	0.0317	CbGbCtD
Conjugated Estrogens—ABCC2—Cisplatin—bone cancer	0.00996	0.03	CbGbCtD
Conjugated Estrogens—ABCC1—Doxorubicin—bone cancer	0.00902	0.0272	CbGbCtD
Conjugated Estrogens—ABCG2—Cisplatin—bone cancer	0.00901	0.0271	CbGbCtD
Conjugated Estrogens—ABCC1—Methotrexate—bone cancer	0.00874	0.0263	CbGbCtD
Conjugated Estrogens—SLCO1A2—Methotrexate—bone cancer	0.0078	0.0235	CbGbCtD
Conjugated Estrogens—SLCO1B1—Methotrexate—bone cancer	0.00736	0.0222	CbGbCtD
Conjugated Estrogens—SLC22A8—Methotrexate—bone cancer	0.0068	0.0205	CbGbCtD
Conjugated Estrogens—ABCC2—Doxorubicin—bone cancer	0.00668	0.0201	CbGbCtD
Conjugated Estrogens—ABCC2—Methotrexate—bone cancer	0.00647	0.0195	CbGbCtD
Conjugated Estrogens—ABCG2—Doxorubicin—bone cancer	0.00604	0.0182	CbGbCtD
Conjugated Estrogens—ABCG2—Methotrexate—bone cancer	0.00585	0.0176	CbGbCtD
Conjugated Estrogens—SLC22A6—Methotrexate—bone cancer	0.00473	0.0143	CbGbCtD
Conjugated Estrogens—ABCB1—Cisplatin—bone cancer	0.00325	0.00978	CbGbCtD
Conjugated Estrogens—ABCB1—Doxorubicin—bone cancer	0.00218	0.00655	CbGbCtD
Conjugated Estrogens—ABCB1—Methotrexate—bone cancer	0.00211	0.00635	CbGbCtD
Conjugated Estrogens—CYP3A4—Doxorubicin—bone cancer	0.0013	0.00393	CbGbCtD
Conjugated Estrogens—Ethinyl Estradiol—NR1I2—bone cancer	0.000589	0.309	CrCbGaD
Conjugated Estrogens—Estradiol—NR1I2—bone cancer	0.000389	0.204	CrCbGaD
Conjugated Estrogens—Exemestane—CYP3A4—bone cancer	0.000275	0.144	CrCbGaD
Conjugated Estrogens—Estramustine—CYP3A4—bone cancer	0.000199	0.104	CrCbGaD
Conjugated Estrogens—Estropipate—CYP3A4—bone cancer	0.000163	0.0855	CrCbGaD
Conjugated Estrogens—Ethinyl Estradiol—CYP3A4—bone cancer	0.000117	0.0611	CrCbGaD
Conjugated Estrogens—Estrone—CYP3A4—bone cancer	0.000102	0.0532	CrCbGaD
Conjugated Estrogens—Abdominal discomfort—Methotrexate—bone cancer	8.04e-05	0.00144	CcSEcCtD
Conjugated Estrogens—Mood swings—Doxorubicin—bone cancer	7.96e-05	0.00143	CcSEcCtD
Conjugated Estrogens—Musculoskeletal discomfort—Cisplatin—bone cancer	7.92e-05	0.00142	CcSEcCtD
Conjugated Estrogens—Abdominal distension—Epirubicin—bone cancer	7.9e-05	0.00142	CcSEcCtD
Conjugated Estrogens—Blood creatinine increased—Doxorubicin—bone cancer	7.87e-05	0.00141	CcSEcCtD
Conjugated Estrogens—Dysphagia—Epirubicin—bone cancer	7.85e-05	0.00141	CcSEcCtD
Conjugated Estrogens—Asthma—Epirubicin—bone cancer	7.85e-05	0.00141	CcSEcCtD
Conjugated Estrogens—Influenza—Epirubicin—bone cancer	7.85e-05	0.00141	CcSEcCtD
Conjugated Estrogens—Dysuria—Methotrexate—bone cancer	7.84e-05	0.00141	CcSEcCtD
Conjugated Estrogens—Dehydration—Doxorubicin—bone cancer	7.81e-05	0.0014	CcSEcCtD
Conjugated Estrogens—Paraesthesia—Cisplatin—bone cancer	7.8e-05	0.0014	CcSEcCtD
Conjugated Estrogens—Upper respiratory tract infection—Methotrexate—bone cancer	7.79e-05	0.0014	CcSEcCtD
Conjugated Estrogens—Dyspnoea—Cisplatin—bone cancer	7.75e-05	0.00139	CcSEcCtD
Conjugated Estrogens—Estradiol—CYP3A4—bone cancer	7.7e-05	0.0403	CrCbGaD
Conjugated Estrogens—Pancreatitis—Epirubicin—bone cancer	7.69e-05	0.00138	CcSEcCtD
Conjugated Estrogens—Hypokalaemia—Doxorubicin—bone cancer	7.64e-05	0.00137	CcSEcCtD
Conjugated Estrogens—Breast disorder—Doxorubicin—bone cancer	7.59e-05	0.00136	CcSEcCtD
Conjugated Estrogens—Decreased appetite—Cisplatin—bone cancer	7.55e-05	0.00136	CcSEcCtD
Conjugated Estrogens—Bronchitis—Epirubicin—bone cancer	7.55e-05	0.00136	CcSEcCtD
Conjugated Estrogens—Gastrointestinal disorder—Cisplatin—bone cancer	7.5e-05	0.00135	CcSEcCtD
Conjugated Estrogens—Infestation NOS—Methotrexate—bone cancer	7.48e-05	0.00134	CcSEcCtD
Conjugated Estrogens—Infestation—Methotrexate—bone cancer	7.48e-05	0.00134	CcSEcCtD
Conjugated Estrogens—Depression—Methotrexate—bone cancer	7.45e-05	0.00134	CcSEcCtD
Conjugated Estrogens—Pain—Cisplatin—bone cancer	7.43e-05	0.00134	CcSEcCtD
Conjugated Estrogens—Renal failure—Methotrexate—bone cancer	7.35e-05	0.00132	CcSEcCtD
Conjugated Estrogens—Dysuria—Epirubicin—bone cancer	7.34e-05	0.00132	CcSEcCtD
Conjugated Estrogens—Abdominal distension—Doxorubicin—bone cancer	7.31e-05	0.00131	CcSEcCtD
Conjugated Estrogens—Upper respiratory tract infection—Epirubicin—bone cancer	7.29e-05	0.00131	CcSEcCtD
Conjugated Estrogens—Dysphagia—Doxorubicin—bone cancer	7.26e-05	0.0013	CcSEcCtD
Conjugated Estrogens—Influenza—Doxorubicin—bone cancer	7.26e-05	0.0013	CcSEcCtD
Conjugated Estrogens—Asthma—Doxorubicin—bone cancer	7.26e-05	0.0013	CcSEcCtD
Conjugated Estrogens—Weight increased—Epirubicin—bone cancer	7.14e-05	0.00128	CcSEcCtD
Conjugated Estrogens—Pancreatitis—Doxorubicin—bone cancer	7.12e-05	0.00128	CcSEcCtD
Conjugated Estrogens—Hyperglycaemia—Epirubicin—bone cancer	7.08e-05	0.00127	CcSEcCtD
Conjugated Estrogens—Hepatobiliary disease—Methotrexate—bone cancer	7.07e-05	0.00127	CcSEcCtD
Conjugated Estrogens—Infestation NOS—Epirubicin—bone cancer	7e-05	0.00126	CcSEcCtD
Conjugated Estrogens—Infestation—Epirubicin—bone cancer	7e-05	0.00126	CcSEcCtD
Conjugated Estrogens—Bronchitis—Doxorubicin—bone cancer	6.98e-05	0.00125	CcSEcCtD
Conjugated Estrogens—Renal failure—Epirubicin—bone cancer	6.88e-05	0.00124	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Cisplatin—bone cancer	6.87e-05	0.00123	CcSEcCtD
Conjugated Estrogens—Neuropathy peripheral—Epirubicin—bone cancer	6.86e-05	0.00123	CcSEcCtD
Conjugated Estrogens—Dysuria—Doxorubicin—bone cancer	6.79e-05	0.00122	CcSEcCtD
Conjugated Estrogens—Upper respiratory tract infection—Doxorubicin—bone cancer	6.75e-05	0.00121	CcSEcCtD
Conjugated Estrogens—Pharyngitis—Methotrexate—bone cancer	6.66e-05	0.0012	CcSEcCtD
Conjugated Estrogens—Hepatobiliary disease—Epirubicin—bone cancer	6.62e-05	0.00119	CcSEcCtD
Conjugated Estrogens—Weight increased—Doxorubicin—bone cancer	6.61e-05	0.00119	CcSEcCtD
Conjugated Estrogens—Sinusitis—Epirubicin—bone cancer	6.56e-05	0.00118	CcSEcCtD
Conjugated Estrogens—Hyperglycaemia—Doxorubicin—bone cancer	6.55e-05	0.00118	CcSEcCtD
Conjugated Estrogens—Infestation NOS—Doxorubicin—bone cancer	6.47e-05	0.00116	CcSEcCtD
Conjugated Estrogens—Infestation—Doxorubicin—bone cancer	6.47e-05	0.00116	CcSEcCtD
Conjugated Estrogens—Visual impairment—Methotrexate—bone cancer	6.47e-05	0.00116	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Cisplatin—bone cancer	6.4e-05	0.00115	CcSEcCtD
Conjugated Estrogens—Renal failure—Doxorubicin—bone cancer	6.36e-05	0.00114	CcSEcCtD
Conjugated Estrogens—Erythema multiforme—Methotrexate—bone cancer	6.34e-05	0.00114	CcSEcCtD
Conjugated Estrogens—Neuropathy peripheral—Doxorubicin—bone cancer	6.34e-05	0.00114	CcSEcCtD
Conjugated Estrogens—Rhinitis—Epirubicin—bone cancer	6.3e-05	0.00113	CcSEcCtD
Conjugated Estrogens—Eye disorder—Methotrexate—bone cancer	6.27e-05	0.00113	CcSEcCtD
Conjugated Estrogens—Hypoaesthesia—Epirubicin—bone cancer	6.25e-05	0.00112	CcSEcCtD
Conjugated Estrogens—Asthenia—Cisplatin—bone cancer	6.23e-05	0.00112	CcSEcCtD
Conjugated Estrogens—Pharyngitis—Epirubicin—bone cancer	6.23e-05	0.00112	CcSEcCtD
Conjugated Estrogens—Cardiac disorder—Methotrexate—bone cancer	6.23e-05	0.00112	CcSEcCtD
Conjugated Estrogens—Oedema peripheral—Epirubicin—bone cancer	6.19e-05	0.00111	CcSEcCtD
Conjugated Estrogens—Hepatobiliary disease—Doxorubicin—bone cancer	6.12e-05	0.0011	CcSEcCtD
Conjugated Estrogens—Angiopathy—Methotrexate—bone cancer	6.09e-05	0.00109	CcSEcCtD
Conjugated Estrogens—Sinusitis—Doxorubicin—bone cancer	6.07e-05	0.00109	CcSEcCtD
Conjugated Estrogens—Immune system disorder—Methotrexate—bone cancer	6.06e-05	0.00109	CcSEcCtD
Conjugated Estrogens—Visual impairment—Epirubicin—bone cancer	6.05e-05	0.00109	CcSEcCtD
Conjugated Estrogens—Mediastinal disorder—Methotrexate—bone cancer	6.05e-05	0.00109	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Cisplatin—bone cancer	5.94e-05	0.00107	CcSEcCtD
Conjugated Estrogens—Erythema multiforme—Epirubicin—bone cancer	5.94e-05	0.00107	CcSEcCtD
Conjugated Estrogens—Alopecia—Methotrexate—bone cancer	5.93e-05	0.00107	CcSEcCtD
Conjugated Estrogens—Mental disorder—Methotrexate—bone cancer	5.88e-05	0.00106	CcSEcCtD
Conjugated Estrogens—Eye disorder—Epirubicin—bone cancer	5.87e-05	0.00105	CcSEcCtD
Conjugated Estrogens—Erythema—Methotrexate—bone cancer	5.84e-05	0.00105	CcSEcCtD
Conjugated Estrogens—Malnutrition—Methotrexate—bone cancer	5.84e-05	0.00105	CcSEcCtD
Conjugated Estrogens—Cardiac disorder—Epirubicin—bone cancer	5.83e-05	0.00105	CcSEcCtD
Conjugated Estrogens—Rhinitis—Doxorubicin—bone cancer	5.83e-05	0.00105	CcSEcCtD
Conjugated Estrogens—Hypoaesthesia—Doxorubicin—bone cancer	5.78e-05	0.00104	CcSEcCtD
Conjugated Estrogens—Pharyngitis—Doxorubicin—bone cancer	5.77e-05	0.00104	CcSEcCtD
Conjugated Estrogens—Oedema peripheral—Doxorubicin—bone cancer	5.72e-05	0.00103	CcSEcCtD
Conjugated Estrogens—Dysgeusia—Methotrexate—bone cancer	5.72e-05	0.00103	CcSEcCtD
Conjugated Estrogens—Angiopathy—Epirubicin—bone cancer	5.7e-05	0.00102	CcSEcCtD
Conjugated Estrogens—Immune system disorder—Epirubicin—bone cancer	5.67e-05	0.00102	CcSEcCtD
Conjugated Estrogens—Mediastinal disorder—Epirubicin—bone cancer	5.66e-05	0.00102	CcSEcCtD
Conjugated Estrogens—Back pain—Methotrexate—bone cancer	5.65e-05	0.00102	CcSEcCtD
Conjugated Estrogens—Arrhythmia—Epirubicin—bone cancer	5.61e-05	0.00101	CcSEcCtD
Conjugated Estrogens—Visual impairment—Doxorubicin—bone cancer	5.6e-05	0.00101	CcSEcCtD
Conjugated Estrogens—Alopecia—Epirubicin—bone cancer	5.55e-05	0.000997	CcSEcCtD
Conjugated Estrogens—Vomiting—Cisplatin—bone cancer	5.52e-05	0.000993	CcSEcCtD
Conjugated Estrogens—Vision blurred—Methotrexate—bone cancer	5.51e-05	0.000989	CcSEcCtD
Conjugated Estrogens—Mental disorder—Epirubicin—bone cancer	5.5e-05	0.000989	CcSEcCtD
Conjugated Estrogens—Erythema multiforme—Doxorubicin—bone cancer	5.49e-05	0.000987	CcSEcCtD
Conjugated Estrogens—Rash—Cisplatin—bone cancer	5.48e-05	0.000985	CcSEcCtD
Conjugated Estrogens—Dermatitis—Cisplatin—bone cancer	5.47e-05	0.000984	CcSEcCtD
Conjugated Estrogens—Malnutrition—Epirubicin—bone cancer	5.47e-05	0.000983	CcSEcCtD
Conjugated Estrogens—Erythema—Epirubicin—bone cancer	5.47e-05	0.000983	CcSEcCtD
Conjugated Estrogens—Eye disorder—Doxorubicin—bone cancer	5.43e-05	0.000976	CcSEcCtD
Conjugated Estrogens—Cardiac disorder—Doxorubicin—bone cancer	5.39e-05	0.000969	CcSEcCtD
Conjugated Estrogens—Flatulence—Epirubicin—bone cancer	5.39e-05	0.000968	CcSEcCtD
Conjugated Estrogens—Tension—Epirubicin—bone cancer	5.36e-05	0.000964	CcSEcCtD
Conjugated Estrogens—Dysgeusia—Epirubicin—bone cancer	5.35e-05	0.000962	CcSEcCtD
Conjugated Estrogens—Nervousness—Epirubicin—bone cancer	5.31e-05	0.000954	CcSEcCtD
Conjugated Estrogens—ABCC4—NRF2 pathway—TGFBR2—bone cancer	5.3e-05	0.0012	CbGpPWpGaD
Conjugated Estrogens—ABCC4—NRF2 pathway—GSTP1—bone cancer	5.3e-05	0.0012	CbGpPWpGaD
Conjugated Estrogens—Back pain—Epirubicin—bone cancer	5.29e-05	0.00095	CcSEcCtD
Conjugated Estrogens—Angiopathy—Doxorubicin—bone cancer	5.27e-05	0.000947	CcSEcCtD
Conjugated Estrogens—Muscle spasms—Epirubicin—bone cancer	5.26e-05	0.000945	CcSEcCtD
Conjugated Estrogens—Immune system disorder—Doxorubicin—bone cancer	5.25e-05	0.000943	CcSEcCtD
Conjugated Estrogens—Vertigo—Methotrexate—bone cancer	5.25e-05	0.000943	CcSEcCtD
Conjugated Estrogens—Mediastinal disorder—Doxorubicin—bone cancer	5.24e-05	0.000941	CcSEcCtD
Conjugated Estrogens—Arrhythmia—Doxorubicin—bone cancer	5.19e-05	0.000933	CcSEcCtD
Conjugated Estrogens—ESR1—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	5.18e-05	0.00117	CbGpPWpGaD
Conjugated Estrogens—ESR1—ATF-2 transcription factor network—RB1—bone cancer	5.17e-05	0.00117	CbGpPWpGaD
Conjugated Estrogens—Nausea—Cisplatin—bone cancer	5.16e-05	0.000927	CcSEcCtD
Conjugated Estrogens—Vision blurred—Epirubicin—bone cancer	5.15e-05	0.000926	CcSEcCtD
Conjugated Estrogens—Alopecia—Doxorubicin—bone cancer	5.13e-05	0.000923	CcSEcCtD
Conjugated Estrogens—Cough—Methotrexate—bone cancer	5.1e-05	0.000916	CcSEcCtD
Conjugated Estrogens—Mental disorder—Doxorubicin—bone cancer	5.09e-05	0.000915	CcSEcCtD
Conjugated Estrogens—SLC10A1—Metabolism—NT5C3A—bone cancer	5.08e-05	0.00115	CbGpPWpGaD
Conjugated Estrogens—Convulsion—Methotrexate—bone cancer	5.06e-05	0.00091	CcSEcCtD
Conjugated Estrogens—Erythema—Doxorubicin—bone cancer	5.06e-05	0.000909	CcSEcCtD
Conjugated Estrogens—Malnutrition—Doxorubicin—bone cancer	5.06e-05	0.000909	CcSEcCtD
Conjugated Estrogens—Flatulence—Doxorubicin—bone cancer	4.98e-05	0.000896	CcSEcCtD
Conjugated Estrogens—ESR1—Plasma membrane estrogen receptor signaling—MMP9—bone cancer	4.98e-05	0.00113	CbGpPWpGaD
Conjugated Estrogens—Arthralgia—Methotrexate—bone cancer	4.97e-05	0.000894	CcSEcCtD
Conjugated Estrogens—Myalgia—Methotrexate—bone cancer	4.97e-05	0.000894	CcSEcCtD
Conjugated Estrogens—Chest pain—Methotrexate—bone cancer	4.97e-05	0.000894	CcSEcCtD
Conjugated Estrogens—Tension—Doxorubicin—bone cancer	4.96e-05	0.000892	CcSEcCtD
Conjugated Estrogens—ESR1—ATF-2 transcription factor network—MMP2—bone cancer	4.96e-05	0.00112	CbGpPWpGaD
Conjugated Estrogens—Dysgeusia—Doxorubicin—bone cancer	4.95e-05	0.00089	CcSEcCtD
Conjugated Estrogens—CYP1A2—Tryptophan metabolism—CYP3A4—bone cancer	4.94e-05	0.00112	CbGpPWpGaD
Conjugated Estrogens—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	4.94e-05	0.000888	CcSEcCtD
Conjugated Estrogens—SLC22A11—Transmembrane transport of small molecules—TUBB2A—bone cancer	4.92e-05	0.00111	CbGpPWpGaD
Conjugated Estrogens—Nervousness—Doxorubicin—bone cancer	4.91e-05	0.000883	CcSEcCtD
Conjugated Estrogens—Vertigo—Epirubicin—bone cancer	4.91e-05	0.000883	CcSEcCtD
Conjugated Estrogens—SLCO1B3—Transmembrane transport of small molecules—TUBB4B—bone cancer	4.91e-05	0.00111	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Platelet activation, signaling and aggregation—GNA11—bone cancer	4.9e-05	0.00111	CbGpPWpGaD
Conjugated Estrogens—Syncope—Epirubicin—bone cancer	4.9e-05	0.000881	CcSEcCtD
Conjugated Estrogens—Back pain—Doxorubicin—bone cancer	4.89e-05	0.000879	CcSEcCtD
Conjugated Estrogens—Muscle spasms—Doxorubicin—bone cancer	4.86e-05	0.000874	CcSEcCtD
Conjugated Estrogens—ESR1—FOXA1 transcription factor network—JUN—bone cancer	4.84e-05	0.0011	CbGpPWpGaD
Conjugated Estrogens—Palpitations—Epirubicin—bone cancer	4.83e-05	0.000868	CcSEcCtD
Conjugated Estrogens—Loss of consciousness—Epirubicin—bone cancer	4.8e-05	0.000864	CcSEcCtD
Conjugated Estrogens—Cough—Epirubicin—bone cancer	4.77e-05	0.000857	CcSEcCtD
Conjugated Estrogens—Anaphylactic shock—Methotrexate—bone cancer	4.77e-05	0.000857	CcSEcCtD
Conjugated Estrogens—Vision blurred—Doxorubicin—bone cancer	4.77e-05	0.000857	CcSEcCtD
Conjugated Estrogens—Convulsion—Epirubicin—bone cancer	4.74e-05	0.000851	CcSEcCtD
Conjugated Estrogens—Infection—Methotrexate—bone cancer	4.74e-05	0.000851	CcSEcCtD
Conjugated Estrogens—COMT—Metabolism—NDUFA12—bone cancer	4.7e-05	0.00106	CbGpPWpGaD
Conjugated Estrogens—Nervous system disorder—Methotrexate—bone cancer	4.68e-05	0.00084	CcSEcCtD
Conjugated Estrogens—Chest pain—Epirubicin—bone cancer	4.65e-05	0.000836	CcSEcCtD
Conjugated Estrogens—Arthralgia—Epirubicin—bone cancer	4.65e-05	0.000836	CcSEcCtD
Conjugated Estrogens—Myalgia—Epirubicin—bone cancer	4.65e-05	0.000836	CcSEcCtD
Conjugated Estrogens—Anxiety—Epirubicin—bone cancer	4.64e-05	0.000834	CcSEcCtD
Conjugated Estrogens—ESR1—Integrated Breast Cancer Pathway—ATF1—bone cancer	4.63e-05	0.00105	CbGpPWpGaD
Conjugated Estrogens—Skin disorder—Methotrexate—bone cancer	4.63e-05	0.000832	CcSEcCtD
Conjugated Estrogens—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	4.62e-05	0.000831	CcSEcCtD
Conjugated Estrogens—ESR1—Regulation of nuclear SMAD2/3 signaling—CDK4—bone cancer	4.61e-05	0.00104	CbGpPWpGaD
Conjugated Estrogens—Hyperhidrosis—Methotrexate—bone cancer	4.61e-05	0.000828	CcSEcCtD
Conjugated Estrogens—ESR2—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	4.6e-05	0.00104	CbGpPWpGaD
Conjugated Estrogens—Vertigo—Doxorubicin—bone cancer	4.54e-05	0.000817	CcSEcCtD
Conjugated Estrogens—Anorexia—Methotrexate—bone cancer	4.54e-05	0.000817	CcSEcCtD
Conjugated Estrogens—Syncope—Doxorubicin—bone cancer	4.54e-05	0.000815	CcSEcCtD
Conjugated Estrogens—ESR1—Gene Expression—ZNF77—bone cancer	4.53e-05	0.00103	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	4.52e-05	0.00102	CbGpPWpGaD
Conjugated Estrogens—Palpitations—Doxorubicin—bone cancer	4.47e-05	0.000803	CcSEcCtD
Conjugated Estrogens—ABCC2—NRF2 pathway—GSTP1—bone cancer	4.47e-05	0.00101	CbGpPWpGaD
Conjugated Estrogens—ABCC2—NRF2 pathway—TGFBR2—bone cancer	4.47e-05	0.00101	CbGpPWpGaD
Conjugated Estrogens—Oedema—Epirubicin—bone cancer	4.46e-05	0.000802	CcSEcCtD
Conjugated Estrogens—Anaphylactic shock—Epirubicin—bone cancer	4.46e-05	0.000802	CcSEcCtD
Conjugated Estrogens—ESR1—Integrated Breast Cancer Pathway—CHEK2—bone cancer	4.46e-05	0.00101	CbGpPWpGaD
Conjugated Estrogens—Hypotension—Methotrexate—bone cancer	4.45e-05	0.000801	CcSEcCtD
Conjugated Estrogens—ABCC4—Platelet activation, signaling and aggregation—IL3—bone cancer	4.45e-05	0.00101	CbGpPWpGaD
Conjugated Estrogens—Loss of consciousness—Doxorubicin—bone cancer	4.45e-05	0.000799	CcSEcCtD
Conjugated Estrogens—Infection—Epirubicin—bone cancer	4.43e-05	0.000797	CcSEcCtD
Conjugated Estrogens—ABCC3—Transmembrane transport of small molecules—TUBB4B—bone cancer	4.43e-05	0.001	CbGpPWpGaD
Conjugated Estrogens—Cough—Doxorubicin—bone cancer	4.41e-05	0.000793	CcSEcCtD
Conjugated Estrogens—Shock—Epirubicin—bone cancer	4.39e-05	0.000789	CcSEcCtD
Conjugated Estrogens—ESR2—Gene Expression—FUS—bone cancer	4.39e-05	0.000994	CbGpPWpGaD
Conjugated Estrogens—Convulsion—Doxorubicin—bone cancer	4.38e-05	0.000788	CcSEcCtD
Conjugated Estrogens—Nervous system disorder—Epirubicin—bone cancer	4.38e-05	0.000786	CcSEcCtD
Conjugated Estrogens—Tachycardia—Epirubicin—bone cancer	4.35e-05	0.000783	CcSEcCtD
Conjugated Estrogens—SLC22A8—Transmembrane transport of small molecules—TUBB4B—bone cancer	4.35e-05	0.000984	CbGpPWpGaD
Conjugated Estrogens—Musculoskeletal discomfort—Methotrexate—bone cancer	4.34e-05	0.000781	CcSEcCtD
Conjugated Estrogens—Skin disorder—Epirubicin—bone cancer	4.33e-05	0.000779	CcSEcCtD
Conjugated Estrogens—Hyperhidrosis—Epirubicin—bone cancer	4.31e-05	0.000775	CcSEcCtD
Conjugated Estrogens—Insomnia—Methotrexate—bone cancer	4.31e-05	0.000775	CcSEcCtD
Conjugated Estrogens—Myalgia—Doxorubicin—bone cancer	4.31e-05	0.000774	CcSEcCtD
Conjugated Estrogens—Chest pain—Doxorubicin—bone cancer	4.31e-05	0.000774	CcSEcCtD
Conjugated Estrogens—Arthralgia—Doxorubicin—bone cancer	4.31e-05	0.000774	CcSEcCtD
Conjugated Estrogens—Anxiety—Doxorubicin—bone cancer	4.29e-05	0.000771	CcSEcCtD
Conjugated Estrogens—Paraesthesia—Methotrexate—bone cancer	4.28e-05	0.000769	CcSEcCtD
Conjugated Estrogens—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	4.28e-05	0.000769	CcSEcCtD
Conjugated Estrogens—Anorexia—Epirubicin—bone cancer	4.25e-05	0.000764	CcSEcCtD
Conjugated Estrogens—Dyspnoea—Methotrexate—bone cancer	4.25e-05	0.000764	CcSEcCtD
Conjugated Estrogens—SLCO1B3—Transmembrane transport of small molecules—TUBB2A—bone cancer	4.24e-05	0.00096	CbGpPWpGaD
Conjugated Estrogens—Somnolence—Methotrexate—bone cancer	4.24e-05	0.000762	CcSEcCtD
Conjugated Estrogens—Dyspepsia—Methotrexate—bone cancer	4.2e-05	0.000754	CcSEcCtD
Conjugated Estrogens—Hypotension—Epirubicin—bone cancer	4.17e-05	0.000749	CcSEcCtD
Conjugated Estrogens—ABCC4—Transmembrane transport of small molecules—TUBB4B—bone cancer	4.17e-05	0.000944	CbGpPWpGaD
Conjugated Estrogens—Decreased appetite—Methotrexate—bone cancer	4.14e-05	0.000745	CcSEcCtD
Conjugated Estrogens—Anaphylactic shock—Doxorubicin—bone cancer	4.13e-05	0.000742	CcSEcCtD
Conjugated Estrogens—Oedema—Doxorubicin—bone cancer	4.13e-05	0.000742	CcSEcCtD
Conjugated Estrogens—Gastrointestinal disorder—Methotrexate—bone cancer	4.12e-05	0.00074	CcSEcCtD
Conjugated Estrogens—ESR1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	4.11e-05	0.000932	CbGpPWpGaD
Conjugated Estrogens—Fatigue—Methotrexate—bone cancer	4.11e-05	0.000739	CcSEcCtD
Conjugated Estrogens—Infection—Doxorubicin—bone cancer	4.1e-05	0.000737	CcSEcCtD
Conjugated Estrogens—Pain—Methotrexate—bone cancer	4.08e-05	0.000733	CcSEcCtD
Conjugated Estrogens—Musculoskeletal discomfort—Epirubicin—bone cancer	4.06e-05	0.000731	CcSEcCtD
Conjugated Estrogens—Shock—Doxorubicin—bone cancer	4.06e-05	0.00073	CcSEcCtD
Conjugated Estrogens—Nervous system disorder—Doxorubicin—bone cancer	4.05e-05	0.000728	CcSEcCtD
Conjugated Estrogens—Insomnia—Epirubicin—bone cancer	4.04e-05	0.000725	CcSEcCtD
Conjugated Estrogens—Tachycardia—Doxorubicin—bone cancer	4.03e-05	0.000724	CcSEcCtD
Conjugated Estrogens—Skin disorder—Doxorubicin—bone cancer	4.01e-05	0.000721	CcSEcCtD
Conjugated Estrogens—Paraesthesia—Epirubicin—bone cancer	4.01e-05	0.00072	CcSEcCtD
Conjugated Estrogens—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	3.99e-05	0.000905	CbGpPWpGaD
Conjugated Estrogens—Hyperhidrosis—Doxorubicin—bone cancer	3.99e-05	0.000717	CcSEcCtD
Conjugated Estrogens—Dyspnoea—Epirubicin—bone cancer	3.98e-05	0.000715	CcSEcCtD
Conjugated Estrogens—Somnolence—Epirubicin—bone cancer	3.97e-05	0.000713	CcSEcCtD
Conjugated Estrogens—CYP1A2—Oxidation by Cytochrome P450—CYP3A4—bone cancer	3.94e-05	0.000893	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Fluoropyrimidine Activity—TP53—bone cancer	3.94e-05	0.000892	CbGpPWpGaD
Conjugated Estrogens—Anorexia—Doxorubicin—bone cancer	3.94e-05	0.000707	CcSEcCtD
Conjugated Estrogens—Dyspepsia—Epirubicin—bone cancer	3.93e-05	0.000706	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Methotrexate—bone cancer	3.9e-05	0.000701	CcSEcCtD
Conjugated Estrogens—COMT—Metabolism—NT5C3A—bone cancer	3.89e-05	0.000882	CbGpPWpGaD
Conjugated Estrogens—Decreased appetite—Epirubicin—bone cancer	3.88e-05	0.000697	CcSEcCtD
Conjugated Estrogens—ESR1—Integrated Breast Cancer Pathway—TGFBR2—bone cancer	3.86e-05	0.000876	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Transmembrane transport of small molecules—TUBB4B—bone cancer	3.86e-05	0.000874	CbGpPWpGaD
Conjugated Estrogens—Hypotension—Doxorubicin—bone cancer	3.86e-05	0.000693	CcSEcCtD
Conjugated Estrogens—Gastrointestinal disorder—Epirubicin—bone cancer	3.85e-05	0.000692	CcSEcCtD
Conjugated Estrogens—Fatigue—Epirubicin—bone cancer	3.85e-05	0.000691	CcSEcCtD
Conjugated Estrogens—SLCO1B3—Metabolism—NDUFA12—bone cancer	3.84e-05	0.00087	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—bone cancer	3.84e-05	0.000869	CbGpPWpGaD
Conjugated Estrogens—ESR1—ATF-2 transcription factor network—JUN—bone cancer	3.83e-05	0.000867	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Transmembrane transport of small molecules—TUBB2A—bone cancer	3.82e-05	0.000867	CbGpPWpGaD
Conjugated Estrogens—Constipation—Epirubicin—bone cancer	3.82e-05	0.000686	CcSEcCtD
Conjugated Estrogens—Pain—Epirubicin—bone cancer	3.82e-05	0.000686	CcSEcCtD
Conjugated Estrogens—COMT—Transmission across Chemical Synapses—BRAF—bone cancer	3.81e-05	0.000864	CbGpPWpGaD
Conjugated Estrogens—Urticaria—Methotrexate—bone cancer	3.79e-05	0.000681	CcSEcCtD
Conjugated Estrogens—ESR1—Integrated Breast Cancer Pathway—BRCA2—bone cancer	3.78e-05	0.000856	CbGpPWpGaD
Conjugated Estrogens—Abdominal pain—Methotrexate—bone cancer	3.77e-05	0.000677	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Methotrexate—bone cancer	3.77e-05	0.000677	CcSEcCtD
Conjugated Estrogens—Musculoskeletal discomfort—Doxorubicin—bone cancer	3.76e-05	0.000676	CcSEcCtD
Conjugated Estrogens—SLC22A8—Transmembrane transport of small molecules—TUBB2A—bone cancer	3.75e-05	0.00085	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	3.74e-05	0.000848	CbGpPWpGaD
Conjugated Estrogens—Insomnia—Doxorubicin—bone cancer	3.73e-05	0.000671	CcSEcCtD
Conjugated Estrogens—Paraesthesia—Doxorubicin—bone cancer	3.71e-05	0.000666	CcSEcCtD
Conjugated Estrogens—ESR1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	3.69e-05	0.000837	CbGpPWpGaD
Conjugated Estrogens—Dyspnoea—Doxorubicin—bone cancer	3.68e-05	0.000661	CcSEcCtD
Conjugated Estrogens—ESR1—Aryl Hydrocarbon Receptor—EGFR—bone cancer	3.67e-05	0.000832	CbGpPWpGaD
Conjugated Estrogens—Somnolence—Doxorubicin—bone cancer	3.67e-05	0.00066	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Epirubicin—bone cancer	3.65e-05	0.000656	CcSEcCtD
Conjugated Estrogens—Dyspepsia—Doxorubicin—bone cancer	3.63e-05	0.000653	CcSEcCtD
Conjugated Estrogens—SLC22A6—Transmembrane transport of small molecules—TUBB4B—bone cancer	3.63e-05	0.000822	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Transmembrane transport of small molecules—TUBB2A—bone cancer	3.6e-05	0.000815	CbGpPWpGaD
Conjugated Estrogens—Decreased appetite—Doxorubicin—bone cancer	3.59e-05	0.000645	CcSEcCtD
Conjugated Estrogens—ESR1—Validated nuclear estrogen receptor alpha network—JUN—bone cancer	3.59e-05	0.000813	CbGpPWpGaD
Conjugated Estrogens—Gastrointestinal disorder—Doxorubicin—bone cancer	3.56e-05	0.000641	CcSEcCtD
Conjugated Estrogens—Fatigue—Doxorubicin—bone cancer	3.56e-05	0.00064	CcSEcCtD
Conjugated Estrogens—Urticaria—Epirubicin—bone cancer	3.54e-05	0.000637	CcSEcCtD
Conjugated Estrogens—Constipation—Doxorubicin—bone cancer	3.53e-05	0.000634	CcSEcCtD
Conjugated Estrogens—Pain—Doxorubicin—bone cancer	3.53e-05	0.000634	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Epirubicin—bone cancer	3.53e-05	0.000634	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Epirubicin—bone cancer	3.53e-05	0.000634	CcSEcCtD
Conjugated Estrogens—ABCC2—Transmembrane transport of small molecules—TUBB4B—bone cancer	3.51e-05	0.000796	CbGpPWpGaD
Conjugated Estrogens—Hypersensitivity—Methotrexate—bone cancer	3.51e-05	0.000631	CcSEcCtD
Conjugated Estrogens—ESR2—SIDS Susceptibility Pathways—JUN—bone cancer	3.49e-05	0.00079	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Transmembrane transport of small molecules—TUBB4B—bone cancer	3.47e-05	0.000787	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—NDUFA12—bone cancer	3.46e-05	0.000785	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—bone cancer	3.46e-05	0.000784	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	3.43e-05	0.000778	CbGpPWpGaD
Conjugated Estrogens—ABCG2—HIF-1-alpha transcription factor network—JUN—bone cancer	3.43e-05	0.000776	CbGpPWpGaD
Conjugated Estrogens—Asthenia—Methotrexate—bone cancer	3.42e-05	0.000615	CcSEcCtD
Conjugated Estrogens—ESR1—Regulation of Telomerase—JUN—bone cancer	3.42e-05	0.000774	CbGpPWpGaD
Conjugated Estrogens—ESR2—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	3.41e-05	0.000773	CbGpPWpGaD
Conjugated Estrogens—Gastrointestinal pain—Doxorubicin—bone cancer	3.38e-05	0.000607	CcSEcCtD
Conjugated Estrogens—Pruritus—Methotrexate—bone cancer	3.37e-05	0.000606	CcSEcCtD
Conjugated Estrogens—ESR1—AP-1 transcription factor network—JUN—bone cancer	3.34e-05	0.000757	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Transmembrane transport of small molecules—TUBB2A—bone cancer	3.33e-05	0.000755	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Transmembrane transport of small molecules—TUBB4B—bone cancer	3.3e-05	0.000747	CbGpPWpGaD
Conjugated Estrogens—ESR2—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	3.29e-05	0.000745	CbGpPWpGaD
Conjugated Estrogens—Hypersensitivity—Epirubicin—bone cancer	3.29e-05	0.000591	CcSEcCtD
Conjugated Estrogens—Urticaria—Doxorubicin—bone cancer	3.28e-05	0.000589	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Doxorubicin—bone cancer	3.26e-05	0.000587	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Doxorubicin—bone cancer	3.26e-05	0.000587	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Methotrexate—bone cancer	3.26e-05	0.000586	CcSEcCtD
Conjugated Estrogens—ESR1—LKB1 signaling events—TP53—bone cancer	3.26e-05	0.000737	CbGpPWpGaD
Conjugated Estrogens—ESR1—AP-1 transcription factor network—MMP9—bone cancer	3.25e-05	0.000736	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	3.24e-05	0.000734	CbGpPWpGaD
Conjugated Estrogens—Asthenia—Epirubicin—bone cancer	3.2e-05	0.000575	CcSEcCtD
Conjugated Estrogens—COMT—Transmission across Chemical Synapses—MDM2—bone cancer	3.19e-05	0.000723	CbGpPWpGaD
Conjugated Estrogens—ESR1—Generic Transcription Pathway—NR1I2—bone cancer	3.18e-05	0.000721	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—NT5C3A—bone cancer	3.18e-05	0.000721	CbGpPWpGaD
Conjugated Estrogens—Pruritus—Epirubicin—bone cancer	3.16e-05	0.000567	CcSEcCtD
Conjugated Estrogens—Dizziness—Methotrexate—bone cancer	3.15e-05	0.000567	CcSEcCtD
Conjugated Estrogens—SLC22A6—Transmembrane transport of small molecules—TUBB2A—bone cancer	3.13e-05	0.000709	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	3.13e-05	0.000709	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Transmembrane transport of small molecules—TUBB4B—bone cancer	3.05e-05	0.000692	CbGpPWpGaD
Conjugated Estrogens—Diarrhoea—Epirubicin—bone cancer	3.05e-05	0.000549	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Doxorubicin—bone cancer	3.04e-05	0.000547	CcSEcCtD
Conjugated Estrogens—ESR2—Gene Expression—NR1I2—bone cancer	3.04e-05	0.000689	CbGpPWpGaD
Conjugated Estrogens—ABCC2—Transmembrane transport of small molecules—TUBB2A—bone cancer	3.03e-05	0.000687	CbGpPWpGaD
Conjugated Estrogens—Vomiting—Methotrexate—bone cancer	3.03e-05	0.000545	CcSEcCtD
Conjugated Estrogens—SLCO1A2—Metabolism—NDUFA12—bone cancer	3.02e-05	0.000683	CbGpPWpGaD
Conjugated Estrogens—Rash—Methotrexate—bone cancer	3.01e-05	0.00054	CcSEcCtD
Conjugated Estrogens—Dermatitis—Methotrexate—bone cancer	3e-05	0.00054	CcSEcCtD
Conjugated Estrogens—ABCC1—Transmembrane transport of small molecules—TUBB2A—bone cancer	3e-05	0.000679	CbGpPWpGaD
Conjugated Estrogens—Headache—Methotrexate—bone cancer	2.99e-05	0.000537	CcSEcCtD
Conjugated Estrogens—ESR1—Regulation of nuclear SMAD2/3 signaling—JUN—bone cancer	2.97e-05	0.000673	CbGpPWpGaD
Conjugated Estrogens—ESR2—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	2.97e-05	0.000672	CbGpPWpGaD
Conjugated Estrogens—Asthenia—Doxorubicin—bone cancer	2.96e-05	0.000532	CcSEcCtD
Conjugated Estrogens—Dizziness—Epirubicin—bone cancer	2.95e-05	0.00053	CcSEcCtD
Conjugated Estrogens—Pruritus—Doxorubicin—bone cancer	2.92e-05	0.000525	CcSEcCtD
Conjugated Estrogens—COMT—Neuronal System—BRAF—bone cancer	2.92e-05	0.000662	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—NT5C3A—bone cancer	2.87e-05	0.00065	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Transmembrane transport of small molecules—TUBB2A—bone cancer	2.85e-05	0.000645	CbGpPWpGaD
Conjugated Estrogens—Vomiting—Epirubicin—bone cancer	2.84e-05	0.00051	CcSEcCtD
Conjugated Estrogens—Nausea—Methotrexate—bone cancer	2.83e-05	0.000509	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Doxorubicin—bone cancer	2.82e-05	0.000508	CcSEcCtD
Conjugated Estrogens—Rash—Epirubicin—bone cancer	2.81e-05	0.000506	CcSEcCtD
Conjugated Estrogens—Dermatitis—Epirubicin—bone cancer	2.81e-05	0.000505	CcSEcCtD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	2.81e-05	0.000637	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Breast Cancer Pathway—CDK4—bone cancer	2.8e-05	0.000635	CbGpPWpGaD
Conjugated Estrogens—Headache—Epirubicin—bone cancer	2.8e-05	0.000502	CcSEcCtD
Conjugated Estrogens—ABCC4—Hemostasis—SPARC—bone cancer	2.76e-05	0.000626	CbGpPWpGaD
Conjugated Estrogens—Dizziness—Doxorubicin—bone cancer	2.73e-05	0.000491	CcSEcCtD
Conjugated Estrogens—ABCC1—Metabolism—NDUFA12—bone cancer	2.71e-05	0.000615	CbGpPWpGaD
Conjugated Estrogens—ESR1—Regulation of Telomerase—EGFR—bone cancer	2.69e-05	0.000609	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Aryl Hydrocarbon Receptor—RB1—bone cancer	2.66e-05	0.000603	CbGpPWpGaD
Conjugated Estrogens—Nausea—Epirubicin—bone cancer	2.65e-05	0.000476	CcSEcCtD
Conjugated Estrogens—ABCG2—Transmembrane transport of small molecules—TUBB2A—bone cancer	2.64e-05	0.000597	CbGpPWpGaD
Conjugated Estrogens—Vomiting—Doxorubicin—bone cancer	2.62e-05	0.000472	CcSEcCtD
Conjugated Estrogens—ESR1—Signaling by ERBB4—KIT—bone cancer	2.62e-05	0.000594	CbGpPWpGaD
Conjugated Estrogens—Rash—Doxorubicin—bone cancer	2.6e-05	0.000468	CcSEcCtD
Conjugated Estrogens—Dermatitis—Doxorubicin—bone cancer	2.6e-05	0.000467	CcSEcCtD
Conjugated Estrogens—Headache—Doxorubicin—bone cancer	2.59e-05	0.000465	CcSEcCtD
Conjugated Estrogens—SLCO1B1—Metabolism—NDUFA12—bone cancer	2.58e-05	0.000584	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Hemostasis—GNA11—bone cancer	2.53e-05	0.000573	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Phase II conjugation—GSTP1—bone cancer	2.51e-05	0.00057	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—NT5C3A—bone cancer	2.5e-05	0.000566	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Breast Cancer Pathway—BRAF—bone cancer	2.48e-05	0.000562	CbGpPWpGaD
Conjugated Estrogens—Nausea—Doxorubicin—bone cancer	2.45e-05	0.000441	CcSEcCtD
Conjugated Estrogens—COMT—Neuronal System—MDM2—bone cancer	2.45e-05	0.000554	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Breast Cancer Pathway—RB1—bone cancer	2.44e-05	0.000552	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	2.39e-05	0.000541	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—NDUFA12—bone cancer	2.39e-05	0.000541	CbGpPWpGaD
Conjugated Estrogens—ESR2—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	2.33e-05	0.000528	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	2.32e-05	0.000526	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Hemostasis—IL3—bone cancer	2.29e-05	0.000519	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Tryptophan metabolism—MDM2—bone cancer	2.27e-05	0.000514	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—NT5C3A—bone cancer	2.25e-05	0.00051	CbGpPWpGaD
Conjugated Estrogens—ESR2—Gene Expression—EIF2S1—bone cancer	2.25e-05	0.000509	CbGpPWpGaD
Conjugated Estrogens—SLC10A1—Metabolism—ENO2—bone cancer	2.23e-05	0.000504	CbGpPWpGaD
Conjugated Estrogens—ESR1—Gene Expression—FUS—bone cancer	2.21e-05	0.000501	CbGpPWpGaD
Conjugated Estrogens—ESR1—AP-1 transcription factor network—TP53—bone cancer	2.2e-05	0.000499	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	2.19e-05	0.000496	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	2.18e-05	0.000493	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—NT5C3A—bone cancer	2.14e-05	0.000484	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Breast Cancer Pathway—MDM2—bone cancer	2.08e-05	0.000471	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling by ERBB4—MDM2—bone cancer	2.07e-05	0.000468	CbGpPWpGaD
Conjugated Estrogens—SLC10A1—Metabolism—DHFR—bone cancer	2.06e-05	0.000468	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Arachidonic acid metabolism—PTGS2—bone cancer	2.05e-05	0.000464	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	1.98e-05	0.000449	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—NT5C3A—bone cancer	1.98e-05	0.000448	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	1.97e-05	0.000447	CbGpPWpGaD
Conjugated Estrogens—ESR2—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	1.96e-05	0.000444	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	1.95e-05	0.000443	CbGpPWpGaD
Conjugated Estrogens—ESR2—Gene Expression—EZH2—bone cancer	1.95e-05	0.000442	CbGpPWpGaD
Conjugated Estrogens—SLC10A1—Metabolism—GNA11—bone cancer	1.93e-05	0.000437	CbGpPWpGaD
Conjugated Estrogens—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	1.85e-05	0.00042	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Breast Cancer Pathway—JUN—bone cancer	1.81e-05	0.000409	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	1.75e-05	0.000397	CbGpPWpGaD
Conjugated Estrogens—SLC10A1—Metabolism—CYP3A4—bone cancer	1.75e-05	0.000396	CbGpPWpGaD
Conjugated Estrogens—SLC10A1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.74e-05	0.000394	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	1.72e-05	0.00039	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Biological oxidations—CYP3A4—bone cancer	1.72e-05	0.00039	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—ENO2—bone cancer	1.71e-05	0.000386	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	1.7e-05	0.000384	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	1.66e-05	0.000376	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	1.66e-05	0.000375	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	1.65e-05	0.000374	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—DHFR—bone cancer	1.58e-05	0.000358	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	1.55e-05	0.000352	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	1.55e-05	0.000352	CbGpPWpGaD
Conjugated Estrogens—ESR1—Gene Expression—NR1I2—bone cancer	1.53e-05	0.000347	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Hemostasis—PLAU—bone cancer	1.5e-05	0.000341	CbGpPWpGaD
Conjugated Estrogens—SLC10A1—Metabolism—GSTP1—bone cancer	1.5e-05	0.000339	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	1.5e-05	0.000339	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—GNA11—bone cancer	1.48e-05	0.000335	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Biological oxidations—GSTP1—bone cancer	1.47e-05	0.000333	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	1.45e-05	0.000329	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	1.43e-05	0.000323	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Breast Cancer Pathway—EGFR—bone cancer	1.42e-05	0.000322	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling by ERBB4—EGFR—bone cancer	1.41e-05	0.00032	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—ENO2—bone cancer	1.39e-05	0.000316	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—CYP3A4—bone cancer	1.34e-05	0.000304	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—DHFR—bone cancer	1.29e-05	0.000293	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—NDUFA12—bone cancer	1.29e-05	0.000293	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—ENO2—bone cancer	1.26e-05	0.000285	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	1.23e-05	0.000278	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—GNA11—bone cancer	1.21e-05	0.000274	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Breast Cancer Pathway—TP53—bone cancer	1.19e-05	0.00027	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—ENO2—bone cancer	1.18e-05	0.000267	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	1.18e-05	0.000266	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—DHFR—bone cancer	1.17e-05	0.000264	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—RGS1—bone cancer	1.15e-05	0.00026	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—GRM4—bone cancer	1.15e-05	0.00026	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—GSTP1—bone cancer	1.15e-05	0.00026	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Biological oxidations—GSTP1—bone cancer	1.14e-05	0.000257	CbGpPWpGaD
Conjugated Estrogens—ESR1—Gene Expression—EIF2S1—bone cancer	1.13e-05	0.000256	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	1.12e-05	0.000254	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—CYP3A4—bone cancer	1.1e-05	0.000248	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—ENO2—bone cancer	1.09e-05	0.000248	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—DHFR—bone cancer	1.09e-05	0.000247	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—GNA11—bone cancer	1.09e-05	0.000247	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.09e-05	0.000247	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—NT5C3A—bone cancer	1.07e-05	0.000242	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—NDUFA12—bone cancer	1.03e-05	0.000234	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—DHFR—bone cancer	1.02e-05	0.00023	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—GRM1—bone cancer	9.97e-06	0.000226	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—CYP3A4—bone cancer	9.88e-06	0.000224	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	9.87e-06	0.000224	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—ENO2—bone cancer	9.85e-06	0.000223	CbGpPWpGaD
Conjugated Estrogens—ESR1—Gene Expression—EZH2—bone cancer	9.83e-06	0.000223	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	9.83e-06	0.000223	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—GNA11—bone cancer	9.49e-06	0.000215	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—GSTP1—bone cancer	9.37e-06	0.000212	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—ENO2—bone cancer	9.36e-06	0.000212	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—DHFR—bone cancer	9.14e-06	0.000207	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	9.11e-06	0.000206	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	8.78e-06	0.000199	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—DHFR—bone cancer	8.69e-06	0.000197	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—ENO2—bone cancer	8.67e-06	0.000196	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—CYP3A4—bone cancer	8.61e-06	0.000195	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	8.56e-06	0.000194	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—GNA11—bone cancer	8.54e-06	0.000194	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—NT5C3A—bone cancer	8.54e-06	0.000194	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—GSTP1—bone cancer	8.45e-06	0.000192	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—GNA11—bone cancer	8.12e-06	0.000184	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—DHFR—bone cancer	8.04e-06	0.000182	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—NDUFA12—bone cancer	7.96e-06	0.00018	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	7.91e-06	0.000179	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—TGFBR2—bone cancer	7.91e-06	0.000179	CbGpPWpGaD
Conjugated Estrogens—SLC10A1—Metabolism—PTGS2—bone cancer	7.75e-06	0.000176	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—CYP3A4—bone cancer	7.74e-06	0.000175	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	7.7e-06	0.000175	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—GNA11—bone cancer	7.52e-06	0.00017	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—GSTP1—bone cancer	7.36e-06	0.000167	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—CYP3A4—bone cancer	7.36e-06	0.000167	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	7.32e-06	0.000166	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—SMO—bone cancer	7.02e-06	0.000159	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—CYP3A4—bone cancer	6.81e-06	0.000154	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—GSTP1—bone cancer	6.62e-06	0.00015	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—NT5C3A—bone cancer	6.59e-06	0.000149	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—GNA11—bone cancer	6.42e-06	0.000146	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—GSTP1—bone cancer	6.29e-06	0.000143	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	6.22e-06	0.000141	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Hemostasis—TP53—bone cancer	6.04e-06	0.000137	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—ATF1—bone cancer	5.97e-06	0.000135	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—PTGS2—bone cancer	5.94e-06	0.000135	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—GSTP1—bone cancer	5.83e-06	0.000132	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—IL3—bone cancer	5.82e-06	0.000132	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—KIT—bone cancer	5.4e-06	0.000122	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	5.22e-06	0.000118	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—BRAF—bone cancer	5.07e-06	0.000115	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—TGFBR2—bone cancer	4.98e-06	0.000113	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—PTGS2—bone cancer	4.85e-06	0.00011	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—ENO2—bone cancer	4.69e-06	0.000106	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—IGF1R—bone cancer	4.69e-06	0.000106	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—PTGS2—bone cancer	4.38e-06	9.92e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—DHFR—bone cancer	4.35e-06	9.85e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—MDM2—bone cancer	4.25e-06	9.63e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—PTGS2—bone cancer	4.1e-06	9.28e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—GNA11—bone cancer	4.06e-06	9.21e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—PTGS2—bone cancer	3.81e-06	8.64e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—ENO2—bone cancer	3.74e-06	8.48e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—CYP3A4—bone cancer	3.68e-06	8.35e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—DHFR—bone cancer	3.47e-06	7.86e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—PTGS2—bone cancer	3.43e-06	7.77e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—KIT—bone cancer	3.4e-06	7.7e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—PTGS2—bone cancer	3.26e-06	7.39e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—GNA11—bone cancer	3.24e-06	7.35e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—BRAF—bone cancer	3.19e-06	7.24e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—GSTP1—bone cancer	3.15e-06	7.14e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—PTGS2—bone cancer	3.02e-06	6.84e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—CYP3A4—bone cancer	2.94e-06	6.66e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.93e-06	6.63e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—EGFR—bone cancer	2.9e-06	6.58e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—ENO2—bone cancer	2.89e-06	6.54e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—DHFR—bone cancer	2.68e-06	6.07e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—MDM2—bone cancer	2.68e-06	6.06e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—GSTP1—bone cancer	2.52e-06	5.7e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—GNA11—bone cancer	2.5e-06	5.67e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—JUN—bone cancer	2.33e-06	5.27e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—MMP9—bone cancer	2.26e-06	5.13e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—GSTP1—bone cancer	1.94e-06	4.4e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—EGFR—bone cancer	1.83e-06	4.14e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PTGS2—bone cancer	1.63e-06	3.7e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—TP53—bone cancer	1.54e-06	3.48e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PTGS2—bone cancer	1.3e-06	2.95e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PTGS2—bone cancer	1.01e-06	2.28e-05	CbGpPWpGaD
